LakeShore Biopharma Co. L... (LSB)
2.75
-0.02 (-0.72%)
At close: Mar 24, 2025, 3:59 PM
2.75
-0.12%
After-hours: Mar 24, 2025, 07:26 PM EDT
-0.72% (1D)
| Bid | 2.46 |
| Market Cap | 52.47M |
| Revenue (ttm) | 515.25M |
| Net Income (ttm) | -470.92M |
| EPS (ttm) | -2.85 |
| PE Ratio (ttm) | -0.96 |
| Forward PE | -11.24 |
| Analyst | n/a |
| Ask | 3.04 |
| Volume | 31,132 |
| Avg. Volume (20D) | 14,243 |
| Open | 2.68 |
| Previous Close | 2.77 |
| Day's Range | 2.50 - 2.78 |
| 52-Week Range | 1.81 - 11.20 |
| Beta | 0.70 |
About LSB
LakeShore Biopharma Co., Ltd, a biopharmaceutical company, engages in discovering, developing, manufacturing, and commercializing of vaccines and therapeutic biologics for infectious diseases and cancer. The company develops a proprietary PIKA immunomodulating technology platform and a series of product targeting PIKA rabies vaccine, PIKA recombinant COVID-19 vaccine, and PIKA YS-ON-001. It operates in China, the United States, Singapore, the Uni...
Industry Biotechnology
Sector Healthcare
IPO Date Aug 5, 2021
Employees 758
Stock Exchange NASDAQ
Ticker Symbol LSB
Website https://www.ysbiopharm.com
5 months ago
+21.15%
LakeShore Biopharma shares are trading higher afte...
Unlock content with
Pro Subscription
7 months ago
+2.5%
LakeShore Biopharma shares are trading higher. The company reported FY24 financial results.
